2m 2m 2m 2m 2m 2m 2m
Bioxytran (BIXT)
OTC
$0.03-$0.00010 (-0.33%)
Price as of Jun 03, 2026- $3.6MMarket Cap
- -78.57%1-Year Change
- BiotechnologyIndustry
Bioxytran (BIXT)
$0.03-$0.00010 (-0.33%)
BIXT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.03 | ||
Change | -$0.00010 (-0.33%) | ||
Open | $0.03 | ||
High | $0.03 | ||
Low | $0.03 | ||
Previous Close | $0.03 | ||
Volume | 107,251 | ||
30-Day Average Volume | 38,944 | ||
1-Week Change | 0.00% | ||
1-Month Change | -1.83% | ||
1-Year Change | -78.57% | ||
3-Year Change | -90.91% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 114.2M | ||
Total Assets | $615,253.00 | ||
Market Cap | $3.6M | ||
Enterprise Value | $5.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.1M | ||
Free Cash Flow | -$238,610.00 | ||
EBIT | -$2.1M | ||
EBITDA | -$2.1M | ||
Net Working Capital | -$4.5M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue